// App-Quantinova.ai

PO0893 : Glomerular Endothelial Glycocalyx Damage Occurs in Human Diabetic Nephropathy and Could Be Prevented by Early Mineralocorticoid Receptor Inhibition

Researchers

Presenter

  • Crompton Michael

Principal Investigators

  • Butler MatthewJ

  • Onions KarenL

  • Ogier AnnaS

  • Welsh GavinIain

  • Foster RebeccaR

  • Satchell SimonC

Medical Centers

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

Disease

  • Diabetic nephropathy

Biomarkers

  • Galectin-3

  • Human albumin

Drug/Treatment

  • Spironolactone

  • Streptozotocin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved